Targeting BTN1A1 in Pd=D-L1-Negative NSCLC: A Clinically Actionable Immune Checkpoint for Docetaxel-Based Combination Therapy

Citations

WEB OF SCIENCE

0

키워드

NelmastobartNSCLC
제목
Targeting BTN1A1 in Pd=D-L1-Negative NSCLC: A Clinically Actionable Immune Checkpoint for Docetaxel-Based Combination Therapy
저자
Yoo, S. S.Lee, S-H.Kim, Y-S.Wu, C.Hong, B-K.
발행일
2025-10
유형
Meeting Abstract
저널명
Journal of Thoracic Oncology
20
10